
Source: Nature Biotechnology 28, 396–398
Social media represent a new way for drug companies to interact with consumers. But transitioning medical communication and marketing campaigns to the internet poses several thorny legal and regulatory issues. Sarah Webb investigates.
Fabio Gratton
Ignite Health(949) 870-9702
Multilanguage free website :: Webnode